In vitro synergistic antiviral activity of ITMN-191, an orally active inhibitor of the hepatitis C virus (HCV) NS3/4A protease, in combination with PEG-Interferon alfa-2A

被引：0
|
作者：
Tan, Hua [1 ]
Seiwert, Scott D. [1 ]
Blatt, Lawrence M. [1 ]
机构：
[1] InterMune Inc, Brisbane, CA USA
来源：
HEPATOLOGY | 2006年 / 44卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
933
引用
收藏
页码：534A / 534A
页数：1
相关论文
共 50 条
  • [1] Preclinical Characteristics of the Hepatitis C Virus NS3/4A Protease Inhibitor ITMN-191 (R7227)
    Seiwert, Scott D.
    Andrews, Steven W.
    Jiang, Yutong
    Serebryany, Vladimir
    Tan, Hua
    Kossen, Karl
    Rajagopalan, P. T. Ravi
    Misialek, Shawn
    Stevens, Sarah K.
    Stoycheva, Antitsa
    Hong, Jin
    Lim, Sharlene R.
    Qin, Xiaoli
    Rieger, Robert
    Condroski, Kevin R.
    Zhang, Hailong
    Do, Mary Geck
    Lemieux, Christine
    Hingorani, Gary P.
    Hartley, Dylan P.
    Josey, John A.
    Pan, Lin
    Beigelman, Leonid
    Blatt, Lawrence M.
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2008, 52 (12) : 4432 - 4441
  • [2] ANTIVIRAL ACTIVITY AND SAFETY OF ITMN-191 IN COMBINATION WITH PEGINTERFERON ALFA-2A AND RIBAVIRIN IN PATIENTS WITH CHRONIC HEPATITIS C VIRUS (HCV)
    Forestier, N.
    Larrey, D.
    Marcellin, P.
    Benhamou, Y.
    Guyader, D.
    Bradford, W.
    Porter, S.
    Patat, A.
    Rouzier, R.
    Zeuzem, S.
    [J]. JOURNAL OF HEPATOLOGY, 2009, 50 : S35 - S35
  • [3] Discovery of Danoprevir (ITMN-191/R7227), a Highly Selective and Potent Inhibitor of Hepatitis C Virus (HCV) NS3/4A Protease
    Jiang, Yutong
    Andrews, Steven W.
    Condroski, Kevin R.
    Buckman, Brad
    Serebryany, Vlad
    Wenglowsky, Steve
    Kennedy, April L.
    Madduru, Machender R.
    Wang, Bin
    Lyon, Michael
    Doherty, George A.
    Woodard, Benjamin T.
    Lemieux, Christine
    Do, Mary Geck
    Zhang, Hailong
    Ballard, Joshua
    Vigers, Guy
    Brandhuber, Barbra J.
    Stengel, Peter
    Josey, John A.
    Beigelman, Leonid
    Blatt, Lawrence
    Seiwert, Scott D.
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2014, 57 (05) : 1753 - 1769
  • [4] Characterization of HCV Ns3/4a protease inhibition by Itmn-191 reveals picomolar potency and slow dissociation: Implications for the use of Itmn-191 in chronic HCV treatment
    Rajagopalan, P. I. Ravi
    Misialek, Shawn
    Blatt, Lawrence M.
    Seiwert, Scott D.
    Kossen, Karl
    [J]. GASTROENTEROLOGY, 2007, 132 (04) : A782 - A782
  • [5] Additive to synergistic antiviral effects of an NS3/4A protease inhibitor (ITMN-191) and an NS5B RNA-dependent RNA polymerase inhibitor (R1479) in an HCV replicon system
    Seiwert, S. D.
    Tan, H.
    Blatt, L. M.
    [J]. JOURNAL OF HEPATOLOGY, 2007, 46 : S167 - S167
  • [6] IMPACT OF LOW DOSE RITONAVIR BOOSTING ON THE PHARMACOKINETICS OF RG7227 (ITMN-191), A HIGHLY POTENT AND SELECTIVE INHIBITOR OF THE HCV NS3/4A PROTEASE
    Haznedar, J. Oe.
    Fretland, J.
    Leong, G.
    Blotner, S.
    Hill, T.
    Smith, P.
    Tran, J. Q.
    [J]. JOURNAL OF HEPATOLOGY, 2010, 52 : S293 - S293
  • [7] Inhibition and Binding Kinetics of the Hepatitis C Virus NS3 Protease Inhibitor ITMN-191 Reveals Tight Binding and Slow Dissociative Behavior
    Rajagopalan, Ravi
    Misialck, Shawn
    Stevens, Sarah K.
    Myszka, David G.
    Brandhuber, Barbara J.
    Ballard, Joshua A.
    Andrews, Steven W.
    Seiwert, Scott D.
    Kossen, Karl
    [J]. BIOCHEMISTRY, 2009, 48 (11) : 2559 - 2568
  • [8] VANIPREVIR HCV NS3/4A Protease Inhibitor Treatment of Hepatitis C
    Hammond, E.
    Lucas, A.
    Lucas, M.
    Phillips, E.
    Gaudieri, S.
    [J]. DRUGS OF THE FUTURE, 2010, 35 (10) : 803 - 813
  • [9] COMBINATION OF THE NS3/4A PROTEASE INHIBITOR ITMN-191 WITH THE ALLOSTERIC NS5B POLYMERASE INHIBITOR ITMN-8020 ENHANCES REPLICON CLEARANCE AND REDUCES THE EMERGENCE OF DRUG RESISTANT VARIANTS
    Tan, H.
    Wang, G.
    Moy, C.
    Kossen, K.
    Rajagopalan, R.
    Misialek, S.
    Ruhrmund, D.
    Hooi, L.
    Snarskaya, N.
    Stoycheva, A.
    Buckman, B.
    Seiwert, S.
    Beigelman, L.
    [J]. JOURNAL OF HEPATOLOGY, 2009, 50 : S340 - S341
  • [10] In Vitro and In Vivo Antiviral Activity and Resistance Profile of the Hepatitis C Virus NS3/4A Protease Inhibitor ABT-450
    Pilot-Matias, Tami
    Tripathi, Rakesh
    Cohen, Daniel
    Gaultier, Isabelle
    Dekhtyar, Tatyana
    Lu, Liangjun
    Reisch, Thomas
    Irvin, Michelle
    Hopkins, Todd
    Pithawalla, Ron
    Middleton, Timothy
    Ng, Teresa
    McDaniel, Keith
    Or, Yat Sun
    Menon, Rajeev
    Kempf, Dale
    Molla, Akhteruzzaman
    Collins, Christine
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2015, 59 (02) : 988 - 997
12345